We serve Chemical Name:2′,5′-dichloroacetoacetanilide CAS:2044-72-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2′,5′-dichloroacetoacetanilide
CAS.NO:2044-72-6
Synonyms:MFCD00018520;EINECS 218-060-3;2,4-DICHLOROQUINOLIN-3-CARBOXALDEHYDE;2′,5′-Dichloroacetoacetanilide;N-Acetoacetyl-2,5-dichloroaniline;Acetoacetic acid-2,5-dichloroanilide;2‘,5‘-Dichloroacetoacetanilide;2′,5′-Dichloroacetoacetanilide
Molecular Formula:C10H9Cl2NO2
Molecular Weight:246.09000
HS Code:2924299090
Physical and Chemical Properties:
Melting point:93-97 °C
Boiling point:410.5ºC at 760 mmHg
Density:1.393g/cm3
Index of Refraction:1.59
PSA:46.17000
Exact Mass:245.00100
LogP:2.98400
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like MFCD00018520 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2′,5′-Dichloroacetoacetanilide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 218-060-3 Use and application,Acetoacetic acid-2,5-dichloroanilide technical grade,usp/ep/jp grade.
Related News: At present, API companies basically use multi-functional and multi-purpose workshops, and the main equipment uses multi-functional reactors to achieve flexible utilization of production capacity. 2′,5′-dichloroacetoacetanilide manufacturer Advanced clinical trials with the Company��s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS. 2′,5′-dichloroacetoacetanilide supplier TSA notified airlines Saturday about the restrictions. CNN is reaching out to TSA for comment. 2′,5′-dichloroacetoacetanilide vendor Advanced clinical trials with the Company��s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS. 2′,5′-dichloroacetoacetanilide factory It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad.
